Company Overview

designed to fulfill your real-world evidence needs

TARGET is an innovative healthcare data company that generates regulatory grade, real-world clinical data and evidence to help guide strategic drug development and commercialization decisions. TARGET partners with industry to accelerate the pathway for understanding the natural history of certain diseases and support the progress of innovative therapies to improve patients’ lives.

TARGET produces meticulously curated, real-world patient data by sponsoring longitudinal observational studies in specific diseases through a network of both academic and community-based sites and principal investigators. The unique foundation of the company, the TARGET model, organizes distinguished disease stakeholders around a common dataset, led by a steering committee of key opinion leaders and an advisory committee of the following participants: industry partners, regulatory authorities, payers, and patient advocacy representatives.

 

Why Should You Partner with TARGET? 

 

MINIMIZE RISK & UNCERTAINTY

TARGET is an independent, credible third-party that creates real-world evidence to confidentially help assist partners with tactical growth within an organization. 

FIT FOR USE, ROBUST PATIENT DATA

With a growing real-world database of thousands of patients across multiple diseases, TARGET enforces strict data quality standards and focuses on both timeliness and accuracy to generate true ‘fit for use’ data. 

NUMEROUS PUBLICATIONS

Publications are a key area of focus for TARGET, and there have been 42 various publications from TARGET to date.

ACCESS THOUSANDS OF BIOSPECIMEN SAMPLES

TARGET has developed a biorepository of more than 100,000 biospecimens partners can query and utilize for their own research purposes on a first-come, first-serve basis.